Report post
Ahead Therapeutics, a new member of CataloniaBio & HealthTech, focuses on Type 1 Diabetes treatment. The company has demonstrated its innovative capabilities and promising therapeutic solutions, earning it a spot as a Top 10 Finalist in the XPANSE 2024 competition. Marti Dalmases, likely associated with the company or the event, highlights Ahead Therapeutics' achievements, showcasing its potential to make significant strides in diabetes treatment.

The World's Leading Crypto Trading Platform

Get my welcome gifts